Lycopene in Preventing Prostate Cancer in Healthy Participants
Prostate Cancer
About this trial
This is an interventional prevention trial for Prostate Cancer focused on measuring prostate cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Healthy participants in good medical condition No chronic medical conditions No regular use of prescription medications No evidence of psychiatric disorder Non-smoker Former smokers allowed provided they have not smoked within the past 3 months No history of alcohol abuse Serum lycopene concentration < 700 nM PATIENT CHARACTERISTICS: Age 18 to 45 Performance status Karnofsky 100% Life expectancy Not specified Hematopoietic Hemoglobin ≥ 13.0 g/dL WBC ≥ 4,000/mm^3 Platelet count 150,000-400,000/mm^3 Hepatic AST and ALT ≤ 75 U/L Bilirubin ≤ 2.0 mg/dL No liver disease Renal Creatinine ≤ 1.5 mg/dL No renal disease Cardiovascular No cardiovascular disease No abnormal EKG Other Within 15% of ideal body weight No history of gastrointestinal malabsorption or other condition that would preclude drug absorption No alcohol consumption within the past 72 hours No allergy to tomato-based products No history of cancer No diabetes mellitus No other illness that would preclude study participation PRIOR CONCURRENT THERAPY: Biologic therapy Not specified Chemotherapy Not specified Endocrine therapy Not specified Radiotherapy Not specified Surgery Not specified Other At least 4 weeks since prior experimental drugs More than 14 days since prior prescription drugs No concurrent participation in another experimental trial No concurrent prescription drugs
Sites / Locations
- University of Illinois at Chicago Cancer Center